Click to open contact form.
Your Global Partners in the Business of Innovation

Representing Orgenesis in Securing $10 Million in Financing and Retaining Ownership of MaSTherCell SA

Publications / Dec 21, 2015

Pearl Cohen represented Orgenesis inc. (OTCQB: ORGS), a cell therapy and regenerative medicine company, in raising a $10,000,000 financing and in the acquisition of MaSTherCell, an advanced cell therapy and bio-manufacturing company based in Europe.

Senior Partner Mark Cohen, Chair of Pearl Cohen’s Life Sciences Group represented Orgenesis in the financing and transaction, and represent the Company in commercial and intellectual property matters.

CLICK HERE for more information.

INNOVATION HIGHLIGHTS